Biotech

Latest Articles

Cassava pays for $40M over allegedly confusing Alzheimer's update

.Cassava Sciences has actually consented to pay $40 million to fix an inspection in to cases it made...

Merck bags alternatives on Evaxion's AI-designed vaccination prospects

.Merck &amp Co. has actually gotten options on pair of Evaxion Biotech vaccine applicants, spending ...

Enanta's RSV antiviral crushes virus-like tons in challenge research study

.Enanta Pharmaceuticals has actually connected its own respiratory system syncytial virus (RSV) anti...

Biogen canisters SAGE-324 partnership after crucial trembling fail

.Biogen has administered the last rites to its cooperation with Sage Rehabs on SAGE-324, scrapping t...

AbbVie Parkinson's medicine coming from $8.7 B Cerevel acquistion credit ratings

.On the very same time that some Parkinson's disease drugs are being cast doubt on, AbbVie has actua...

Arch shuts $3B-plus fund to foster biopharma startups

.On the heels of a $3 billion fund coming from Bain Funding Life Sciences, Arc Endeavor Partners is ...

Orion to use Aitia's 'digital identical twins' to discover brand-new cancer cells medications

.Finnish biotech Orion has snooped potential in Aitia's "electronic identical twin" technician to de...

Windtree's shock med brings up high blood pressure in most recent phase 2 gain

.While Windtree Therapies has actually battled to grow the economic roots needed to endure, a period...

2 cancer biotechs combine, producing international footprint

.OncoC4 is taking AcroImmune-- and also its own internal clinical manufacturing capacities-- under i...

Amgen reports initial stage 3 gain for $400M chronic eczema drug

.Amgen has actually shared (PDF) the first stage 3 data on its own $400 thousand eczema drug, connec...

Biogen, UCB file phase 3 lupus gain after falling short earlier test

.Biogen as well as UCB's gamble on advancing right into phase 3 on the back of an unsuccessful study...

Aptadir wishes brand new RNA inhibitors can easily reverse complicated cancers

.Italian biotech Aptadir Therapeutics has launched along with the pledge that its own pipe of precli...

Wave surfs DMD success to regulators' doors, delivering stockpile

.Wave Lifestyle Sciences has actually fulfilled its goal in a Duchenne muscle dystrophy (DMD) study,...

Sanofi plucks brand new CSO from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is actually returning to the pharma fold, ...

Achilles drops cell therapy system, prepares for unemployments after overlooking 'commercial stability' targets

.Achilles Therapies has actually destroyed its own approach. The British biotech is quiting working ...

Aligos trumpets period 2 MASH gain, lowering liver excess fat around 46%

.Aligos Rehabs is actually heralding a midstage succeed in metabolic-dysfunction affiliated steatohe...

Basilea scores $268M BARDA funding for antifungals, antibiotics

.Basilea Pharmaceutica's work establishing brand-new antifungals has acquired a significant improvem...

Capricor offers Europe civil rights to late-stage DMD therapy for $35M

.Possessing currently gathered up the USA civil rights to Capricor Therapeutics' late-stage Duchenne...

FDA scraps adcomm for Applied's rare condition medicine

.After pushing the selection meeting for Applied Rehabs' metabolic ailment drug govorestat, the FDA ...

Novo inks $600M NanoVation offer to examine hereditary drugs ex-liver

.Novo Nordisk is actually continuing its press into hereditary medicines, accepting compensate NanoV...